November 13, 2025; 8:30 AM
At 8:15 a.m. IST, GIFT Nifty Futures were trading at 25,958 compared with yesterday’s close of 25,875.80
Market Pulse: Confirmed Uptrend
What Changed Over the Night?
- US Markets: Stock futures rebounded after the recent sharp sell-off, supported by signs of easing U.S.–China trade friction. Source: Investopedia
- Asian Markets: Asian equities fell, with major indices dragged down by renewed U.S.–China trade war concerns. Source: globecapital.
- US Dollar Index (DXY): The dollar held near its recent levels, amid mixed signals about possible near-term rate cuts and shifting safe-haven flows. Source: Reuters
- Crude Oil (Brent): Brent crude futures rose about US $63.65 / barrel, up ~1.5% as markets responded to hopes of a thaw in U.S.–China trade tension. Source: Reuters
- USD/INR: The rate was approximately ₹88.66 per US $1, reflecting modest dollar strength against the rupee. Source: ValutaFX
Current Market Status
The Nifty 50 has shifted to a “Confirmed Uptrend” after decisively surpassing its previous rally high of 25,670, registering a new 52-week high at 26,100 on October 17. However, post this “breakout”, the index faced profit booking pressure, leading to a short-term pullback and a breach of the 21-day moving average (DMA).
Looking ahead, we will maintain the “Confirmed Uptrend” stance as long as market action remains constructive. However, if the distribution day count rises or the Nifty breaches key support levels, we may shift the outlook back to “Uptrend Under Pressure” to reflect elevated risk.
- Immediate Resistance: 26,000 – 26,100 (a sustained move above this zone may extend the uptrend)
- Immediate Support: 25,700 (near-term support level)
- Strong Support: 25,300 (key base reinforcing the broader uptrend)
What should you do?
While the broader market remains in a Confirmed Uptrend, overall sentiment has turned constructive with the Nifty hitting fresh highs and leadership expanding across sectors. Strength in key indices, improving breadth, and rising volumes suggest that investors currently have a favorable window to build positions in high-quality stocks.
That said, staying disciplined and selective remains crucial. Investors should focus on fundamentally strong companies breaking out of sound chart patterns, as these have the highest probability of outperforming in a confirmed uptrend.
Our approach continues to emphasize measured exposure and rule-based execution. Here’s what we recommend:
- Focus on leadership: Identify fundamentally sound stocks forming strong base patterns and showing price-volume confirmation.
- Add exposure: Increase allocation progressively as long as both the market and your holdings continue to demonstrate strength.
- Stay disciplined: Follow strict buy and sell rules to protect profits and manage risk effectively.
How are the other Global Markets Performing?
Major equity markets show mixed momentum, with most sustaining uptrends while a few remain under pressure or in early recovery phases.
- Confirmed Uptrend: India, USA, UK, China, Malaysia, Thailand, Brazil, Singapore, Japan, Mexico, Taiwan, South Korea are in a Confirmed Uptrend, reflecting sustained positive momentum and strong underlying market trends.
- Rally Attempt: Germany is currently in a Rally Attempt, indicating early signs of potential recovery; however, confirmation is required before a clear uptrend can be established.
- Uptrend Under Pressure: Canada, Hong Kong and Indonesia face potential weakness, with rising risk of trend reversal if selling pressure persists.
FII-DII activity from the last 5 days
What’s Driving Indian Market?
- Renewed risk-off from global trade and geopolitical jitters: Markets in India are reacting to rising U.S.–China tariff talk and global growth uncertainty, prompting profit-taking and weighing on sentiment. — Source: ap news hub
- Currency & FPI dynamics stabilizing: The Reserve Bank of India’s active support has helped narrow rupee volatility, which in turn is easing one headwind for equities and foreign flows. — Source: The Economic Times
- Domestic structural play intact: Despite external risks, underlying factors such as consumption rebound and infra/capex thrust remain supportive for India’s equity market. — Source: JPMorgan
- Short-term technical caution: Analysts report that the Nifty 50 remains range-bound unless there’s a clear break above key resistance or below support levels, highlighting near-term uncertainty. — Source: Lemonn
- Tail risks persist: While fundamentals are supportive, India still faces risks around global interest rates, export slowdown and weaker corporate earnings which could limit valuation upside. — Source: India Today
Below are the top stock specific news we are tracking (Source: CNBC TV18)
- Tata Steel – Q2 results led by India business with EBITDA per tonne above estimates.
- Mahindra & Mahindra – Signed a 50:50 life insurance JV agreement with Manulife.
- Biocon (Nse) – Exploring a merger of Biocon Biologics with Biocon, as per CNBC-TV18.
- Lloyds Metals & Energy – Reported strong Q2 with net profit up 90% YoY.
- Endurance Technologies – Posted steady Q2 with revenue up 16% YoY.
- Lupin (Nse) – Received US FDA establishment inspection report for Aurangabad facility.
- Pfizer (Nse) – EBITDA rose 21.5% YoY; margins improved to 35.8% vs 32.1%.
- Prestige Estates Prjs. – EBITDA up 44.2% YoY; margins at 37.4% vs 27.4%.
- Honasa Consumer Ltd – Turned EBITDA loss to profit; revenue rose 16.5% YoY.
- Inox Wind – Secured 100 MW order for 3.3 MW turbines in Gujarat.
- Data Patterns (India) – Net profit up 62%; EBITDA at ₹68 Cr vs ₹34.3 Cr YoY.
- Nazara Technologies – Margins at highest level since Q3FY24; mobile gaming revenue up 81%.
- Rites – Won ₹52 Cr contract from Cochin Airport.
- Phoenix Mills – To acquire CPPIB’s stake in arm for ₹276 Cr.
- Man Infraconstruction – EBITDA up 29% YoY; margins at 24.7% vs 12%.
- Guj.Narmada Vly.Fcm. – Profit surged 70% YoY; margin doubled to 9.4% from 4.7%.
- Entero Healthcare Solutions Ltd – EBITDA up 46%; margins improved to 3.93% from 3.26%.
- Sansera Engineering – EBITDA up 7.3%; revenue grew 8% YoY.
- Healthcare Global Ents. – Revenue up 17%; margin rose to 19% vs 17.4%.
- Supriya Lifescience – Revenue up 20%; margin improved to 36.4% vs 35.6%.
Buy Watchlist
Endurance Technologies, Privi Speciality Chemicals, Federal Bank, Titan Company, City Union Bank (Nse), National Aluminium (Nse), Laurus Labs, Shriram Finance
Investing Insights
Weekly Report: Uptrend Persists; Vigilance Needed
IPO Spotlight: Lenskart’s D2C Surge vs. Orkla India’s FMCG Strength
Stocks to Watch: 5 Leaders Nearing Breakout Zones — Amber, CarTrade, SBFC, TBO Tek & Endurance